Lipidomics has so far been primarily concerned with identifying novel methods, but recent applications in diabetes, neurodegenerative diseases, cystic fibrosis, and other respiratory diseases clearly demonstrate the potential utility of lipidomics in both diseases. K generate biomarkers and investigate signaling and metabolic processes.